p53: a cell cycle regulator activated by DNA damage.

Suppr

超能文献

作者信息

Selivanova G, Wiman K G

机构信息

Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden.

出版信息

Adv Cancer Res. 1995;66:143-80. doi: 10.1016/s0065-230x(08)60253-5.

DOI:10.1016/s0065-230x(08)60253-5

PMID:7793313

Abstract

摘要

相似文献

p53: a cell cycle regulator activated by DNA damage.

Adv Cancer Res. 1995;66:143-80. doi: 10.1016/s0065-230x(08)60253-5.

[TP53 tumor suppressor gene: 20 years (and ten thousand mutations) later].[TP53肿瘤抑制基因：20年后（以及一万种突变之后）]

Bull Cancer. 2000 Jan;87(1):11-8.

[Tumor suppressor gene p53].[肿瘤抑制基因p53]

Nihon Rinsho. 1996 Apr;54(4):960-4.

The molecular perspective: p53 tumor suppressor.

Oncologist. 1999;4(2):138-9.

The role of p53-target genes in human cancer.p53靶基因在人类癌症中的作用。

Crit Rev Oncol Hematol. 2000 Jan;33(1):1-6. doi: 10.1016/s1040-8428(99)00051-7.

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.p53肿瘤抑制基因的突变：癌症病因学和分子发病机制的线索

Cancer Res. 1994 Sep 15;54(18):4855-78.

[p53 activation by PI-3K family kinases after DNA double-strand breaks].DNA双链断裂后PI-3K家族激酶对p53的激活作用

Bull Cancer. 2000 Sep;87(9):635-41.

Twenty years of p53 research: structural and functional aspects of the p53 protein.p53研究二十年：p53蛋白的结构与功能方面

Oncogene. 1999 Dec 13;18(53):7621-36. doi: 10.1038/sj.onc.1203285.

Mdmx as an essential regulator of p53 activity.Mdmx作为p53活性的关键调节因子。

Biochem Biophys Res Commun. 2005 Jun 10;331(3):750-60. doi: 10.1016/j.bbrc.2005.03.151.

Regulation of p53 downstream genes.p53下游基因的调控

Semin Cancer Biol. 1998;8(5):345-57. doi: 10.1006/scbi.1998.0097.

引用本文的文献

Implication of the VRK1 chromatin kinase in the signaling responses to DNA damage: a therapeutic target?VRK1 染色质激酶在 DNA 损伤信号反应中的意义：治疗靶点？

Cell Mol Life Sci. 2018 Jul;75(13):2375-2388. doi: 10.1007/s00018-018-2811-2. Epub 2018 Apr 20.

Apoptosis-associated genes related to photodynamic therapy in breast carcinomas.乳腺癌光动力治疗相关凋亡相关基因。

Lasers Med Sci. 2014 Jul;29(4):1429-36. doi: 10.1007/s10103-014-1547-y. Epub 2014 Feb 27.

p53 gene in treatment of hepatic carcinoma: status quo.p53基因在肝癌治疗中的现状

World J Gastroenterol. 2007 Feb 21;13(7):985-92. doi: 10.3748/wjg.v13.i7.985.

Papillary microcarcinomas of the thyroid gland and immunohistochemical analysis of expression of p53 protein in papillary microcarcinomas.甲状腺微小乳头状癌及甲状腺微小乳头状癌中p53蛋白表达的免疫组化分析

J Transl Med. 2006 Jul 5;4:28. doi: 10.1186/1479-5876-4-28.

Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum.在大鼠纹状体中，N-甲基-D-天冬氨酸受体介导的细胞凋亡过程中，核因子κB的核转位上调c-Myc和p53的表达。

J Neurosci. 1999 May 15;19(10):4023-33. doi: 10.1523/JNEUROSCI.19-10-04023.1999.

DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization.p53在包括新位点Ser20在内的N端位点的DNA损伤诱导磷酸化需要四聚化。

EMBO J. 1999 Apr 1;18(7):1815-23. doi: 10.1093/emboj/18.7.1815.

New p53-based anti-cancer therapeutic strategies.基于p53的新型抗癌治疗策略。

Med Oncol. 1998 Dec;15(4):222-8. doi: 10.1007/BF02787204.

Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma.人乳头瘤病毒DNA检测及癌蛋白过表达与扁桃体鳞状细胞癌的不同形态学模式相关。

Am J Pathol. 1998 Jan;152(1):145-56.

p53CP, a putative p53 competing protein that specifically binds to the consensus p53 DNA binding sites: a third member of the p53 family?p53CP，一种假定的p53竞争蛋白，它能特异性结合p53 DNA结合共有序列：p53家族的第三个成员？

Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14753-8. doi: 10.1073/pnas.94.26.14753.

Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter.p53对人IV型胶原酶（明胶酶A或基质金属蛋白酶2）启动子的转录激活作用。

Mol Cell Biol. 1997 Nov;17(11):6330-8. doi: 10.1128/MCB.17.11.6330.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验